Canton Strategic Holdings (CNTN) EPS (Basic) Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 76.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.77% |
| Dec 31, 2025 | 126.73% |
| Sep 30, 2025 | 86.12% |
| Jun 30, 2025 | 73.55% |
| Mar 31, 2025 | 61.18% |
| Dec 31, 2024 | -102.95% |
| Sep 30, 2024 | 93.78% |
| Jun 30, 2024 | 95.35% |
| Mar 31, 2024 | 56.34% |
| Dec 31, 2023 | 477.92% |
| Sep 30, 2023 | -21,800.00% |
| Jun 30, 2023 | -37,285.71% |
| Mar 31, 2023 | -1,985.71% |
| Dec 31, 2022 | -4,868.42% |
| Sep 30, 2022 | -38.46% |
| Jun 30, 2022 | 158.33% |
| Mar 31, 2022 | 20.00% |